Pre-Conference Workshop - Tuesday, 11 June


Molecular Imaging to Accelerate Oncology Drug Development

12:00 - 15:00

This interactive session will be a combination of presentations and discussions designed to take a deep dive into oncology drug design methodology.

Giving greater clarity on the key considerations that must be made to improve the effectiveness of your drug, whilst ensuring the safety of patients. We’ll provide the platform for you to analyse the challenges you are facing, in granular detail. By looking at a variety of different cancers, targets and drugs; this comprehensive session is a “can’t miss” for any radiopharmaceutical drug developer.

Workshop Leaders

Chris Behrenbuch

Chris Behrenbruch
Chief Executive Officer
Telix Pharmaceuticals